Publications

5808 Results

Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study

Authors
GT Budd;C Rankin;LF Hutchins;L Wong;PJ Petruska;K Antman
Journal / Conference
Investigational New Drugs 20:129-132
Year
2002
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-9518

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated Intergroup study

Authors
RE Martell;BL Peterson;HJ Cohen;WP Petros;KR Rai;VA Morrison;L Elias;L Shepherd;J Hines;RA Larson;CA Schiffer;HI Hurwitz
Journal / Conference
Cancer Chemotherapy and Pharmacology 50:37-45
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Overall results of a randomized trial of the Southwest Oncology Group

Authors
VK Sondak;PY Liu;RJ Tuthill;RA Kempf;JM Unger;JA Sosman;JA Thompson;GR Weiss;BG Redman;JG Jakowatz;RD Noyes;LE Flaherty
Journal / Conference
Journal of Clinical Oncology 20(8):2058-2066
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

PK1195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents, by more than one mechanism.

Authors
DE Banker;JJ Cooper;DA Fennell;CL Willman;FR Appelbaum;Cotter
Journal / Conference
Leukemia Research 26:91-106
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
S9617

Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small cell lung cancer

Authors
SD Ramsey;CM Moinpour;LC Lovato;JJ Crowley;P Grevstad;CA Presant;SE Rivkin;K Kelly;DR Gandara
Journal / Conference
Journal of the National Cancer Institute 94(4):291-297
Year
2002
Research Committee(s)
Lung
Study Number(s)
SWOG-9509

Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial

Authors
CM Moinpour;B Lyons;PK Grevstad;LC Lovato;J Crowley;K Czaplicki;ZM Buckner;PA Ganz;K Kelly;DR Gandara
Journal / Conference
Quality of Life Research 11:115-126
Year
2002
Research Committee(s)
Lung
Study Number(s)
SWOG-9509

A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy - Southwest Oncology Group study

Authors
RP Whitehead;JM Unger;LE Flaherty;EH Kraut;GM Mills;CE Klein;RA Chapman;GC Doolittle;N Hammond;VK Sondak
Journal / Conference
Investigational New Drugs 20:105-111
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9505

Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study

Authors
SA Taylor;C Rankin;JJ Townsend;JB Craig;RB Vance;DL Solanki;TD Brown;KA Jaeckle
Journal / Conference
Investigational New Drugs 20:113-115
Year
2002
Research Committee(s)
Brain
Study Number(s)
SWOG-8829

The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study

Authors
JK Weick;JJ Crowley;MA Hussein;DF Moore Jr;B Barlogie
Journal / Conference
Investigational New Drugs 20:117-121
Year
2002
Research Committee(s)
Myeloma
Study Number(s)
S9803

Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients

Authors
JR Berenson;JJ Crowley;TM Grogan;J Zangmeister;AD Briggs;GM Mills;B Barlogie;SE Salmon
Journal / Conference
Blood 99(9):3163-3168
Year
2002
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9210